Related Experiment Video
Updated: Apr 8, 2026

Conscious and Non-conscious Representations of Emotional Faces in Asperger's Syndrome
Published on: July 31, 2016
Effects of Escitalopram Administration on Face Processing in Intermittent Explosive Disorder: An fMRI Study
Henk Cremers1, Royce Lee1, Sarah Keedy1
1Biological Science Division, Department of Psychiatry, University of Chicago, Chicago, IL, USA.
Selective serotonin reuptake inhibitors (SSRIs) like escitalopram may improve intermittent explosive disorder (IED) by enhancing social cognition. This study found escitalopram increased temporal parietal junction (TPJ) activity in IED patients.
Area of Science:
- Neuroscience
- Psychiatry
- Pharmacology
Background:
- Intermittent explosive disorder (IED) is often linked to serotonin system deficits.
- Selective serotonin reuptake inhibitors (SSRIs) are a common treatment approach.
Purpose of the Study:
- To investigate the effects of escitalopram on brain activation during face processing in individuals with IED.
- To explore escitalopram's impact on social-emotional brain regions.
Main Methods:
- A randomized, double-blind, placebo-controlled, counterbalanced fMRI study.
- 17 subjects with IED and 14 healthy controls underwent face processing tasks.
- Analysis focused on group and drug interaction effects on brain activity.
Main Results:
- Group × Drug interactions were observed in the amygdala and left temporal parietal junction (TPJ).
- Escitalopram increased amygdala activation in controls, but not in IED patients.
- IED patients showed increased TPJ activity with escitalopram compared to placebo.
Conclusions:
- SSRI administration may enhance social-cognitive processes, like perspective-taking and empathy, via TPJ activation.
- This enhancement in the TPJ could potentially reduce aggressive tendencies in individuals with IED.
- Further research is needed to understand long-term SSRI effects on social-emotional tasks in IED.
Related Concept Videos
Electroconvulsive Therapy
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
Antidepressant Drugs: MAOIs and Other Agents
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
A study on guinea pigs examined the...

